These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27789479)

  • 1. Design and characterization of an APC-specific serpin for the treatment of hemophilia.
    Polderdijk SG; Adams TE; Ivanciu L; Camire RM; Baglin TP; Huntington JA
    Blood; 2017 Jan; 129(1):105-113. PubMed ID: 27789479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting activated protein C to treat hemophilia.
    Polderdijk SGI; Baglin TP; Huntington JA
    Curr Opin Hematol; 2017 Sep; 24(5):446-452. PubMed ID: 28632502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of serpins specific for activated protein C using a lysate-based screening assay.
    Polderdijk SGI; Huntington JA
    Sci Rep; 2018 Jun; 8(1):8793. PubMed ID: 29884816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serpins, New Therapeutic Targets for Hemophilia.
    Aymonnier K; Kawecki C; Arocas V; Boulaftali Y; Bouton MC
    Thromb Haemost; 2021 Mar; 121(3):261-269. PubMed ID: 32987444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A reactive center loop-based prediction platform to enhance the design of therapeutic SERPINs.
    Sanrattana W; Sefiane T; Smits S; van Kleef ND; Fens MH; Lenting PJ; Maas C; de Maat S
    Proc Natl Acad Sci U S A; 2021 Nov; 118(45):. PubMed ID: 34740972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic residues in the 37-loop of activated protein C modulate inhibition by protein C inhibitor but not by alpha(1)-antitrypsin.
    Glasscock LN; Gerlitz B; Cooper ST; Grinnell BW; Church FC
    Biochim Biophys Acta; 2003 Jun; 1649(1):106-17. PubMed ID: 12818196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of protein C inhibitor activity.
    Neese LL; Pratt CW; Church FC
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):737-46. PubMed ID: 7532447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive site mutants of recombinant protein C inhibitor.
    Cooper ST; Church FC
    Biochim Biophys Acta; 1995 Jan; 1246(1):29-33. PubMed ID: 7811727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
    Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
    Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U; Erhardtsen E
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted inhibition of activated protein C by a non-active-site inhibitory antibody to treat hemophilia.
    Zhao XY; Wilmen A; Wang D; Wang X; Bauzon M; Kim JY; Linden L; Li L; Egner U; Marquardt T; Moosmayer D; Tebbe J; Glück JM; Ellinger P; McLean K; Yuan S; Yegneswaran S; Jiang X; Evans V; Gu JM; Schneider D; Zhu Y; Xu Y; Mallari C; Hesslein A; Wang Y; Schmidt N; Gutberlet K; Ruehl-Fehlert C; Freyberger A; Hermiston T; Patel C; Sim D; Mosnier LO; Laux V
    Nat Commun; 2020 Jun; 11(1):2992. PubMed ID: 32532974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Factor IX Fc Fusion Protein Maintains Full Procoagulant Properties and Exhibits Prolonged Efficacy in Hemophilia B Mice.
    Toby GG; Liu T; Buyue Y; Zhang X; Bitonti AJ; Pierce GF; Sommer JM; Jiang H; Peters RT
    PLoS One; 2016; 11(2):e0148255. PubMed ID: 26840952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and energetic characteristics of the heparin-binding site in antithrombotic protein C.
    Friedrich U; Blom AM; Dahlbäck B; Villoutreix BO
    J Biol Chem; 2001 Jun; 276(26):24122-8. PubMed ID: 11316800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel small molecule inhibitors of activated protein C.
    Sperandio O; Wildhagen KC; Schrijver R; Wielders S; Villoutreix BO; Nicolaes GA
    Thromb Res; 2014 Jun; 133(6):1105-14. PubMed ID: 24513148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin spatial distribution determines protein C activation during hemostasis and thrombosis.
    Marar TT; Matzko CN; Wu J; Esmon CT; Sinno T; Brass LF; Stalker TJ; Tomaiuolo M
    Blood; 2022 Mar; 139(12):1892-1902. PubMed ID: 34890454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting protease nexin-1, a natural anticoagulant serpin, to control bleeding and improve hemostasis in hemophilia.
    Aymonnier K; Kawecki C; Venisse L; Boulaftali Y; Christophe OD; Lenting PJ; Arocas V; de Raucourt E; Denis CV; Bouton MC
    Blood; 2019 Nov; 134(19):1632-1644. PubMed ID: 31383642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and characterization of α1-antitrypsin variants for treatment of contact system-driven thromboinflammation.
    de Maat S; Sanrattana W; Mailer RK; Parr NMJ; Hessing M; Koetsier RM; Meijers JCM; Pasterkamp G; Renné T; Maas C
    Blood; 2019 Nov; 134(19):1658-1669. PubMed ID: 31366623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and characterization of a novel human recombinant factor IX molecule with enhanced in vitro and in vivo clotting activity.
    Perot E; Enjolras N; Le Quellec S; Indalecio A; Girard J; Negrier C; Dargaud Y
    Thromb Res; 2015 May; 135(5):1017-24. PubMed ID: 25795563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
    Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M
    J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.